Individual sympathetic varicosities possess dierent sensitivities to alpha 2 and P2 receptor agonists and antagonists in mouse vas deferens
Introduction
The ecacy of transmitter release from sympathetic terminal varicosities during trains of impulses is modulated by endogenous autoinhibitory substances which include the cotransmitter noradrenaline (Starke et al., 1989; . The extent to which these act by modulating the intra-terminal calcium concentration during and after a train of impulses, by changing the entry of calcium into the varicosities or modifying calcium-induced calcium release in the varicosities or the calcium sequestering processes, is now being elucidated. It has been recently shown that D [Ca 2+ ] v in sympathetic varicosities following an impulse or short train of impulses is due to the in¯ux of calcium ions into the varicosities and not to a signi®cant contribution of calcium from intra-varicosity stores (Brain & Bennett, 1997) . Furthermore, the a 2 antagonist yohimbine has a profound eect on D [Ca 2+ ] v amplitude following short trains of impulses in some sympathetic varicosities without aecting the sequestering processes (Brain & Bennett, 1997; Cheung et al., 1998) . It is therefore likely, at least during short trains of impulses, that a 2 autoreceptors operate by reducing the calcium in¯ux, which reduces transmitter release and subsequently reduces the D [Ca 2+ ] v . Other autoreceptors exist on sympathetic varicosities. There are P1-(A1-) purinoceptors Hoyle et al., 1995) , agonists of which decrease the release of the cotransmitter ATP as indicated by electrophysiological experiments (Sneddon et al., 1984) . The recent discovery that soluble nucleotidases are released from sympathetic nerve terminals with the cotransmitters raises the possibility that adenosine derived from the breakdown of ATP acts on P1-autoreceptors to inhibit transmitter release (Todorov et al., 1997) . However the P1-purinoceptor antagonist 8-phenyltheophylline does not aect the junctional potentials due to sympathetic nerve stimulation so that it is uncertain whether these receptors are functionally relevant . P 2y -purinoceptors also exist on sympathetic varicosities in the mouse vas deferens (von Kugelgen et al., 1989a) . There is good evidence that these are activated by the endogenously released ATP, producing a negative feedback control on ATP release . In the present work an investigation has been made into whether activation of a 2 , P 2y and P1 autoreceptors leads to changes in D [Ca 2+ ] v for all or some varicosities, either during short trains of impulses or during long trains like those typically used in pharmacological experiments in which contraction of the ®nal eector is observed. In addition, the likelihood that autoreceptors modify D [Ca 2+ ] v transients by changing calcium in¯ux or calcium sequestration has been ascertained.
Methods

Tissue preparation
Vasa deferentia were excised from mice (strain Balb/c) aged 5 ± 7 weeks. Animals were anaesthetized with CO 2 then killed by cervical fracture. Animal ethics approval was granted by the Animal Care Ethics Committee, University of Sydney. Both vasa deferentia were removed, together with the connective tissue. The epididymal end of each was pinned to a sheet of Sylgard, and the sheath of epimysium carefully trimmed. This dissection, and the subsequent loading of the dye, was carried out in a bath which was continuously perfused with a Ringer's solution of the following composition (mM): Na 7 , 1.7; glucose, 7.8. In order to maintain the pH the bathing solution was continually bubbled with 95% O 2 and 5% CO 2 .
The cut prostatic end of the vas deferens was secured in a suction electrode and immersed in a solution of Oregon Green TM 488 BAPTA-1, 10 kD dextran (Oregon-BAPTA; Molecular Probes). This concentrated indicator solution was prepared by adding 3 ml of orthophosphate-free ringer's solution to 1 mg of the indicator. In each experiment, 0.2 ± 0.5 ml of this stock solution was used. The dextran linked form of the dye allows orthograde transport of the indicator along the axons to the nerve terminals. The tissue was then left in the bath for 4 ± 5 h to allow time for the sympathetic axons to load with the dye. While loading, the bath was covered to prevent photobleaching of the indicator. The cut end of the vas deferens was then removed from the Oregon-BAPTA solution but was kept in the bath solution for a further 0.5 ± 3 h to reduce nonspeci®c staining of the tissue.
Measurement of the calcium transient
The vas deferens was placed in a bath on the stage of an inverted Leica 4D laser scanning confocal microscope. The bath was continuously perfused with ringer solution, which was bubbled in a reservoir to maintain the correct pH. The base of the bath was a no. 0 coverslip to allow imaging deep within the tissue while using a relatively short working distance objective. The prostatic end (which had been exposed to the dye) was secured in a suction electrode.
The Oregon-BAPTA indicator was excited using an Ar-Kr laser at a wavelength of 488 nm. Fluorescence images were captured using the confocal microscope with an oil immersion 166/0.5 objective, and a 515 nm long pass emission ®lter. The vas deferens was stimulated to initiate action potentials within the axons using an isolated stimulator (Digitimer DS2) triggered by a Master-8 programmable pulse generator (AMPI). The stimulus duration was kept constant at 0.08 ms throughout all experiments. The stimulation threshold voltage was determined by ®nding the smallest applied voltage amplitude which consistently produced a response to a single impulse. The vas deferens was then stimulated at approximately 30% above this threshold value. This stimulus protocol elicits calcium transients which are abolished by TTX and are hence secondary to action potentials (Trout et al., 1999) . All experiments were carried out in the presence of 10 mM nifedipine and 3 mM prazosin in order to reduce the movement artefact induced by contraction. It has been previously shown by us (Brain & Bennett, 1997 ) that nifedipine (even at 20 mM) has no signi®cant response on the amplitude of response to single action potentials (increased by 1+19%, n=5; P=0.95).
The scan rate of the confocal microscope during experiments (1500 lines s 71 ) was such that a full image (2566256 pixels) was captured every 216 ms (which includes the time for the scanner to reset between images). The time of exposure of the sample to the laser was minimized, however a certain amount of photobleaching and toxicity was unavoidable. These eects were particularly troublesome for the experiments involving short trains of impulses since these typically involved small amplitude calcium transients. In these experiments the eects of bleaching and toxicity were compensated for by subtracting the average of several control recordings from the recording of the evoked response.
Recordings were transferred to a Power Macintosh 6200/75 and processed using NIH Image 1.60. For each varicosity a region of interest was de®ned and the mean pixel intensity within this region determined for every image in the recording. Any variation in the position of the varicosity was accounted for by an automated procedure which tracked the varicosity between frames by locating the strongest local¯uorescence signal compared with the background (Brain & Bennett, 1997) . In this way a record of the variation of the mean¯uorescent intensity following an action potential, within a single given varicosity, was obtained.
The change in¯uorescence was converted to a change in calcium concentration via a relationship derived previously for this preparation (Brain & Bennett, 1997 (Brain & Bennett, 1997) .
To test for heterogeneity in the response of dierent varicosities to each drug the following method was used. The null hypothesis was that all varicosities are equally aected by each experimental protocol. In each experimental protocol the average eect of the drug was calculated. An expected response from each varicosity in the presence of the drug was calculated, based on its control response and assuming the null hypothesis. The measured response was compared with the expected response. When at least 25% of the varicosities (and at least two varicosities) had a measured response that was statistically signi®cantly dierent (P50.05) from the expected response then the null hypothesis is violated and hence the response to the experimental protocol was called heterogenous.
2 ] v peak by about 45% (Figure 4b ). One string showed no eects of clonidine (®lled square, Figure 4f ), another possessed only one varicosity that was aected (®lled circle, Figure 4f ), whereas ®ve out of six varicosities were aected on two other strings close to each other in the same preparation (triangles, Figure 4f ; n v =11, n s =4, n e =3). The rate of calcium recovery following a single impulse or short trains of impulses was unaected by clonidine in any varicosity studied (Figure 4c,d) .
] v during long trains of impulses (10 Hz for 30 s) was greatly decreased by clonidine in the majority of varicosities ( Figure 5a ). Signi®cant decreases were observed in ®ve varicosities (n v =9, n s =4, n e =4), with in some cases a decrease of over 75% (Figure 5b ). However some strings possessed varicosities that did not show any changes at all, whilst other strings possessed a minority of varicosities which did not show signi®cant changes (Figure 5b ). It is interesting to note that the varicosities with the highest control plateaus seem to be most aected by clonidine ( Figure 5b ). Overall, the response to clonidine was heterogenous (as described in the Methods) following single impulses, short trains and long trains of impulses.
The eect of an a 2 receptor antagonist on
A check was next made of the ability of endogenously released noradrenaline to aect the a 2 receptors on varicosities, using the a 2 receptor antagonist idazoxan (2 mM). This drug only aected the peak D[Ca ] v reached during long trains of impulses in the presence of idazoxan was increased in a majority of varicosities (Figure 6c ,f). Signi®cant increases of about 80% were detected in six varicosities (n v =11, n s =5, n e =4), with all three varicosities on one string being aected (®lled squares, Figure 6f ) and none on another (®lled triangles, Figure 6f ).
The response to idazoxan was heterogenous (as described in the Methods) following single impulses and long trains of impulses. These observations on the eects of clonidine and idazoxan suggest that about half of the varicosities possess a 2 receptors, that many of these varicosities are on the same string, and that as the endogenous release of noradrenaline is increased by long trains of impulses most of these varicosities have their (Figure 7d ; n v =9, n s =7, n e =4) consistent with the idea that most varicosities possess P 2y autoreceptors, but the amplitude of the change was heterogenous. The P 261 /P 263 receptor agonist a,b-methylene ATP (100 mM) reduced the plateau D [Ca 2+ ] v during long trains of impulses (Figure 7b ), in a minority of varicosities (Figure 7e ; n v =8, n s =5 and n e =4), indicating that most varicosities do not possess P 2x receptors. The response to a,b-methylene ATP was heterogenous (as described in the Methods). There was no evidence for an action of the P1 receptor agonist adenosine These observations on the eects of suramin indicate that P 2 receptors are under tonic control by endogenous ATP. Given the observations that 2-methyl-thio-ATP aects the plateau
] v in most varicosities, described above, the results with suramin suggest that it is the P 2y subclass of P 2 receptors on varicosities which are under the control of endogenously released ATP. In order to check this, the eects of the P 2y antagonist reactive blue (100 mM) on the D[Ca ] v (n v =12, n s =4, n e =3), with two of these occurring on the same string and each of the others on a single string, so that one string possessed varicosities that showed no eects at all (Figure 9f) . Overall, the response to Reactive blue was heterogenous (as described in the Methods) following all stimulus protocols. These results show that most varicosities are not aected by reactive blue at any of the protocols of stimulation used whereas they are by suramin, indicating that types of P 2 receptors other than P 2y might be involved in the modulation of D[Ca ] v began to decline from its peak before the end of the stimulus train (class B and C responses). It may be that in these varicosities the decline in the peak corresponds with the onset of presynaptic autoinhibition of the calcium in¯ux (which may be adrenergic, purinergic or peptidergic). Alternatively, the kinetics of calcium removal or sequestration may change during the stimulus train. For example, the activity of the calcium pump may be upregulated in the presence of an increase in intracellular calcium concentration via a Ca 2+ -calmodulin-dependent pathway (for review, see Monteith & Roufogalis, 1995) , which would lead to either the class B or C responses. It is also possible that the class B and C responses occur as a result of an increasing number of failures to initiate action potentials during the course of prolonged stimulation. We have observed such failures during long trains of stimuli with line scanning confocal microscopy through single varicosities (unpublished observation). The class D responses (which were relatively rarely observed) may occur in varicosities in which calcium sequestration mechanisms begin to fail as the stimulus train progresses.
A constant of 0.42+0.05 s; Brain & Bennett, 1997 ) is signi®cant in determining the plateau concentration, then the change in calcium concentration per impulse is predicted from the derivation in the Appendix to be about 60 nM. This is in agreement with the D[Ca
2+
] v peak of 65+12 nM measured following single impulses that we have previously reported (Brain & Bennett, 1997) . The observed non-linearity of the relationship between frequency and plateau amplitude may be due to more complicated kinetics of calcium sequestration than assumed by the simple ®rst order model. ] v during short trains of impulses by about 40% and during long trains by an even greater percentage in the large majority of varicosities without changing the kinetics of sequestration of calcium, indicating that most varicosities possess a 2 receptors. It is known that prazosin has considerably anity for both a 2B and a 2C adrenoceptors, with pK i for the human isoforms of 7.0 and 7.1 respectively (MarjamaÈ ki et al., 1993) . As the present experiments were carried out in 3 mM prazosin, with the aim of blocking contraction via inhibition of a 1 receptors, we are unable to comment on the presence or action of either a 2B or a 2C adrenoceptor mechanisms in the varicosities. The failure of clonidine to decrease D [Ca 2+ ] v due to a single impulse, except in a small minority of varicosities, was surprising. Although it has been shown previously that clonidine can decrease D [Ca 2+ ] v due to a single impulse (Brain & Bennett, 1997) , the proportion and disposition of varicosities which behave in this ] v were quite heterogeneous across varicosities, with some strings of these remaining entirely unaected and other strings possessing some aected varicosities next to unaected varicosities. The unaected strings existed in too high a number to be attributed to sensory endings, and furthermore all their varicosities showed calcium transients on arrival of a nerve impulse, so that the possibility exists that these strings might belong to terminals that do not release noradrenaline. It is likely that clonidine modulates D [Ca 2+ ] v by decreasing the calcium in¯ux through an N-type like voltage-dependent calcium channel. a 2 receptors on sympathetic neurons inhibit calcium in¯ux through an N-type calcium channel (Boehm & Huck, 1996) although in sympathetic nerve terminals the a 2 receptor mediated changes in transmitter release occur via an o-conotoxin GVIA resistant channel, which is nevertheless a voltage-sensitive calcium channel as it is blocked by cadmium ions (Brock & Cunnane, 1995; Smith & Cunnane, 1996; ] v during a single impulse, consistent with the previously reported action of the a 2 -antagonist yohimbine (Brain & Bennett, 1997) . These results are also consistent with electrophysiological analysis of the eects of these agents on junction potentials in the vas deferens, with clonidine depressing all the junction potentials during a train (Illes & Starke, 1983; Blakeley et al., 1984) and yohimbine increasing all the junction potentials in a train except for the ®rst one (Illes & Starke, 1983; Brock et al., 1990) . These results are to be expected given the fact that the cotransmitter noradrenaline released by an impulse does not act on a 2 autoreceptors to modulate transmitter release by the same impulse (Story et al., 1981; Mayer et al., 1988) . The observation that D [Ca 2+ ] v was unaected by idazoxan during long trains of impulses in whole strings of varicosities is consistent with the failure of clonidine to aect whole strings of varicosities under the same stimulation paradigm, and reinforces the conclusion that some terminals do not possess a 2 adrenoceptors at all.
The eect of purinergic receptor agonists and antagonists on
The P1 receptor agonist adenosine had no signi®cant eect on the great majority of varicosities. On the other hand the P 2y agonist 2-methyl-thio-ATP had a profound eect in decreasing
] v during long trains of impulses in nearly all varicosities, pointing to a widespread distribution of this receptor on varicosities. The P 2x receptor agonist a,bmethylene ATP aected a minority of varicosities, indicating that this receptor is not widely distributed over varicosities.
The signi®cant eect of the P 2 receptor antagonist suramin on varicosities indicates the activation of the P 2y receptor by endogenous ATP. Suramin increased the amplitude of D [Ca 2+ ] v for single impulses as well as for short and long trains of impulses in a high proportion of varicosities without aecting the kinetics of sequestration. Suramin is an antagonist at P2-purinoceptors , blocking membrane currents due to the eects of exogenous ATP acting at P 2x receptors on isolated smooth muscle cells (Hoiting et al., 1990) , the purinergic (P 2x ) phase of the contraction of the vas deferens (von Kugelgen et al., 1989b; Mallard et al., 1992) as well as the excitatory junction potential in the vas deferens due to ATP acting on P 2x receptors (Sneddon, 1992) . However suramin tends to potentiate the contractions produced by exogenous ATP on the vas deferens (Bailey & Hourani, 1994; Reilly & Hirst, 1996) . This apparent contradiction is probably resolved by the discovery that suramin has direct inhibitory eects on ectonucleotidases (Hourani & Chown, 1989; Stout & Kirley, 1995; Ziganshin et al., 1995; Kennedy & Le, 1995 ; also see below). Exogenous ATP is hydrolysed to adenosine by membrane bound ectonucleotidases; the inhibition of the ectonucleotidases with suramin will protect the ATP from hydrolysis and so enhance the contractile response. However the potentiating eect of ] v in any varicosity studied. It is interesting in this regard that Blakeley et al. (1988) ] v due to a single impulse was increased signi®cantly by suramin in most varicosities. As it is unlikely that ATP released by an impulse can act back on the varicosity from which it is released to modulate secretion by the same impulse, it seems that there is an ambient level of ATP (or another endogenous P2-receptor agonist) present at the varicosities in the absence of impulses that regulates the
There is evidence to suggest that suramin increases the over¯ow of transmitter from the vas deferens for long trains of impulses, but not for short trains, an observation that has been interpreted as showing the necessity for prolonged nerve activity before the negative feedback mediated by the P 2y autoreceptors is operative (von Kugelgen et al., 1993) . It might be that a sustained release of ATP from varicosities occurs in the absence of nerve impulses, as indicated by the spontaneous excitatory junction potentials in the vas deferens (Burnstock & Holman, 1962) , or that there is a spontaneous release of ATP from smooth muscle cells Henery et al. 1999) . This spontaneous ATP release could provide a tonic inhibitory eect on evoked release of transmitter through a tonic down regulation of calcium channels on varicosities. ] v transient in most varicosities, the paucity of eects of the P 2y antagonist reactive blue 2 (Burnstock & Warland, 1987) was surprising. Reactive blue 2 acts in the mouse vas deferens to greatly increase the over¯ow of stimulation-evoked noradrenaline . However reactive blue had little eect in potentiating D [Ca 2+ ] v compared with that of suramin for either a single impulse or short trains of impulses, indicating that it is unlikely that suramin is only blocking P 2y receptors on the varicosities, and perhaps pointing to a more eective role of P 2x receptors on varicosities than revealed in the present study. ] v during trains of impulses for some varicosities but not for others. This result is to be expected if the released ATP in the vas deferens is partly metabolized by ATPases before it acts on P 2y autoreceptors to inhibit evoked transmitter release: protecting ATP from metabolism then increases the availability of ATP to act on these autoreceptors and so down-regulate the voltage-dependent calcium channels that control the evoked in¯ux of calcium ions and hence D [Ca 2+ ] v . The fact that ARL 67157 also potentiates the contraction of the vas deferens in response to exogenous ATP (Crack et al., 1995) is simply explained on the eect of this agent in protecting the exogenous ATP from metabolism, and hence increasing its concentration at the postjunctional P 2x receptors. The recent discovery that soluble nucleotidases are secreted along with ATP during evoked transmitter release and that these nucleotidases are inhibited by suramin and ARL 67157 adds a new dimension to the pharmacological analysis of purinergic transmission (Todorov et al., 1997 
Heterogeneity of autoreceptors on varicosities
In this investigation, changes in D [Ca 2+ ] v have been used to determine the actions of adrenergic and purinergic agents on single varicosities. Of course if a particular agent exerts its eect on the varicosities by other means than altering calcium in¯ux or sequestration then this approach is of no use. Adenosine, which is known in many synapses to modulate calcium currents (see for example Bennett & Ho, 1992) ] v recorded in adjacent varicosities has been examined previously using line scans through the varicosities and shown not to occur following a single impulse; there was, however, some evidence for diusion of calcium between varicosities during relatively sustained spontaneous elevations in D [Ca 2+ ] v (lasting over seconds) that sometimes occur in varicosities (Brain & Bennett, 1997 ] v during long trains of impulses indicate that whilst a majority of varicosities were aected there exist whole strings of varicosities that were not and which therefore are unlikely to possess a 2 receptors. Furthermore some varicosities on the same string responded to clonidine, while adjacent ones did not, suggesting that any coupling between the varicosities was too weak to remove the eects of receptor distribution diversity. In contrast, the actions of 2-methyl-thio-ATP on D[Ca ] v to idazoxan was increased during long trains of impulses compared with short trains. If there is no signi®cant pooling of calcium between varicosities during long trains, as discussed above, then the increasing eects of idazoxan at longer trains may be attributed to the greater concentration of noradrenaline in the extracellular space.
It is important to consider the presence of non-sympathetic axons and terminals within the vas deferens. In the monkey vas deferens, about 0.1% of varicosities are sensory (Type V varicosities; Leong & Singh, 1989) . Acetycholinesterase positive ®bres are most densely distributed in the lamina propria, but are also present in the inner part of the smooth musculature. If these results hold for the mouse, then it would be very unlikely that any of the varicosities viewed in these experiments, which are close to the outer surface of the vas deferens, were either sensory or cholinergic.
This work presents a ®rst description of the pharmacology of single varicosities when the agents to be examined might have been expected to exert an eect on intra-varicosity calcium. There are many questions that remain to be addressed. These include whether the number of varicosities examined in the present work are a sucient sample on which to reach general conclusions, or whether there are pharmacological dierences between the subclasses of varicosities de®ned on the basis of the D [Ca 2+ ] v response to long trains of stimuli. A valuable technical addition to the approach here would be to combine confocal imaging of the immunohistochemical localization of receptors on varicosities with the D [Ca 2+ ] v response to stimulation determined for the same varicosities. The distribution of purinergic and adrenergic receptors at single varicosities determined immunohistochemically is now under investigation (Hansen et al., 1998; Dutton et al., 1999) , so that this combined approach, which would couple structure with function, will soon be possible.
